TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/6/23 18:00 | 8/12/22 | ALT | Altimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gill John | MD | D | S | -41 | 15.00 | 0 | -3 | -49 | 3 | D | |||||||||||||||
12/2/20 19:05 | 11/30/20 | ALT | Altimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gill John | MD | D | S | -100 | 11.92 | 0 | -8 | -43 | 11 | D | |||||||||||||||
10/16/20 19:00 | 9/24/20 | ALT | Altimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gill John | MD | D | M.d | 0 | 0.00 | 0 | 17 | 607 | 20 | D | |||||||||||||||
6/6/17 16:49 | 6/2/17 | ALT | Altimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gill John | MD | D | P | 4 | 4.34 | 0 | 1 | 1 | 83 | D | |||||||||||||||
11/23/16 16:47 | 11/22/16 | PIP | Pharmathene, Inc | DE | Health | Drug | Pharmaceutical Preparations | Gill John | MD | DO | P,CEO | M.d | 220 | 2.20 | 2 | 100 | 14 | 822 | D | 100 | 83 | 38 | 21 | 10 | 13 | 5 | 7 | 2 | 0 | 6 | 155 | ||
9/19/16 18:00 | 9/15/16 | PIP | Pharmathene, Inc | DE | Health | Drug | Pharmaceutical Preparations | Gill John | MD | DO | P,CEO | M.dm | 199 | 1.81 | 0 | 110 | 18 | 722 | D | 48 | 85 | 57 | 24 | 7 | 5 | 2 | 3 | 1 | 4 | 1 | 17 | 153 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |